Use of Botulinum Toxin and Pneumoperitoneum for Hernias with Loss of Dominance

Main Article Content

Daniela Medina Correa
Oscar Gregorio Gonzalez Cambero
Raúl Manuel Cota García
Alhan Fernando Castillo Valencia
María Fernanda Lara Solórzano
Sonia Elena Azucar Organista
José Fernando Montiel Castañeda
Brayant López García Montero
Maria del Rocio Barrera Figueroa

Abstract

When the abdominal cavity's material migrates to the hernial sac (HSV) and the HSV/abdominal cavity volume ratio exceeds 25%, systemic alterations known as "loss of domain" occur, resulting in an estimated 5–30% of cases of post-incisional ventral hernia. Usage of botulinum toxin appears to be a secure way to do a tension-free repair on treatment for hernias with loss of dominance.

Article Details

How to Cite
Daniela Medina Correa, Oscar Gregorio Gonzalez Cambero, Raúl Manuel Cota García, Alhan Fernando Castillo Valencia, María Fernanda Lara Solórzano, Sonia Elena Azucar Organista, José Fernando Montiel Castañeda, Brayant López García Montero, & Maria del Rocio Barrera Figueroa. (2024). Use of Botulinum Toxin and Pneumoperitoneum for Hernias with Loss of Dominance. International Journal of Medical Science and Clinical Research Studies, 4(03), 446–448. https://doi.org/10.47191/ijmscrs/v4-i03-16
Section
Articles

References

I. Tuveri, M., Tuveri, A., Nicolo, E., Tsuruma, T., Nagayama, M., Nakano, S., ... & Chen, J. (2015). Topic: Incisional Hernia—“Difficult case” as specialistic case: real loss of substance, multi recurrences, infections, fistulas, lombocel, burst abdomen, reconstruction of the entire wall. Hernia, 19, S225-S236.

II. Afaque, M. Y. (2021). Assessing the complexity of ventral hernia by methods of Tanaka, Sabbagh, Carbonell, and Love. Hernia, 25(2), 557-558.

III. Said, S., Thomas, J., Montelione, K., Fafaj, A., Beffa, L., Krpata, D., ... & Petro, C. (2022). Tanaka score predicts surgical intensive care admission following abdominal wall reconstruction. Hernia, 26(3), 873-880.

IV. Rombaldi, M. C., Barreto, C. G., Peterson, C. A., Cavazzola, L. T., Santis-Isolan, P. M., & Fraga, J. C. (2021). Complex ventral hernia repair in a child: An association of botulinum toxin, progressive pneumoperitoneum and negative pressure therapy. A case report on an arising surgical technique. International Journal of Surgery Case Reports, 81, 105828.

V. Mourad, A. P., De Robles, M. S., & Winn, R. D. (2020). Low-dose pre-operative botulinum toxin A effectively facilitates complex ventral hernia repair: a case report and review of the literature. Medicina, 57(1), 14.

VI. Choudhury, S., Baker, M. R., Chatterjee, S., & Kumar, H. (2021). Botulinum toxin: an update on pharmacology and newer products in development. Toxins, 13(1), 58.

VII. Helm, J. M. (2017). The use of botulinum toxin in abdominal wall reconstruction: A case series.

VIII. Tang, F. X., Ma, N., Huang, E., Ma, T., Liu, C. X., Chen, S., ... & Zhou, T. C. (2022). Botulinum toxin A facilitated laparoscopic repair of complex ventral hernia. Frontiers in Surgery, 8, 803023.

IX. Barst, H. H. (1972). Pneumoperitoneum as an aid in the surgical treatment of giant herniae. Journal of British Surgery, 59(5), 360-364.

X. Tsirline, V. B., Belyansky, I., Klima, D. A., & Heniford, B. T. (2012). 30. Loss of Abdominal Domain. The SAGES Manual of Hernia Repair, 353.

Most read articles by the same author(s)